Top

Gepubliceerd in:

16-01-2024 | Review

Baseline functioning scales of EORTC QLQ-C30 predict overall survival in patients with gastrointestinal cancer: a meta-analysis

Auteurs: Ye Zang, Yue Qiu, Yimeng Sun, Yu Fan

Gepubliceerd in: Quality of Life Research | Uitgave 6/2024

Abstract

Purpose

A consensus has not been reached on the value of quality of life (QoL) as a prognostic factor for survival in gastrointestinal cancer. This meta-analysis aimed to investigate the association between functioning scales of the EORTC QoL Questionnaire Core 30 (QLQ-C30) and the overall survival (OS) in patients with gastrointestinal cancer.

Methods

A systematic literature search was conducted in PubMed, Web of Science, and Embase databases, until February 7, 2023. The studies included were those that investigated the association between baseline QoL measured by the functioning scales of EORTC QLQ-C30 and OS in patients with gastrointestinal cancer. The prognostic capacity of QoL was calculated by pooling the adjusted hazard ratios (HR) with 95% confidence intervals (CI).

Results

Twenty-four studies' analyses reported by 22 eligible articles involving 11,609 patients were included. When compared with good parameters of QoL, poor global QoL (HR 1.81; 95% CI 1.53–2.13), physical functioning (HR 1.51; 95% CI 1.31–1.74), social functioning (HR 1.67; 95% CI 1.30–2.15), and role functioning scale (HR 1.42; 95% CI 1.20–1.29) were significantly associated with decreased OS. For each 10-point increase in QLQ-C30 parameters, the pooled HR of OS was 0.87 (95% CI 0.83–0.92) for global QoL, 0.87 (95% CI 0.83–0.92) for physical functioning, and 0.93 (95% CI 0.88–0.97) for role functioning. However, each 10-point increase in social, emotional, or cognitive functioning scale did not significantly predict OS.

Conclusions

Baseline health-related QoL defined by the physical functioning or global QoL scale of EORTC QLQ-C30 significantly predicts OS in patients with gastrointestinal cancer.

vorige artikel COVID-19-related health utility values and changes in COVID-19 patients and the general population: a scoping review

volgende artikel Quality of life, cognitive and behavioural impairment in people with motor neuron disease: a systematic review

Alleen toegankelijk voor geautoriseerde gebruikers

Kuntz, S., Krieghoff-Henning, E., Kather, J. N., Jutzi, T., Hohn, J., Kiehl, L., Hekler, A., Alwers, E., von Kalle, C., Frohling, S., Utikal, J. S., Brenner, H., Hoffmeister, M., & Brinker, T. J. (2021). Gastrointestinal cancer classification and prognostication from histology using deep learning: Systematic review. European Journal of Cancer, 155, 200–215.PubMedCrossRef

Arnold, M., Abnet, C. C., Neale, R. E., Vignat, J., Giovannucci, E. L., McGlynn, K. A., & Bray, F. (2020). Global burden of 5 major types of gastrointestinal cancer. Gastroenterology, 159(1), 335-349.e15.PubMedCrossRef

Lu, L., Mullins, C. S., Schafmayer, C., Zeissig, S., & Linnebacher, M. (2021). A global assessment of recent trends in gastrointestinal cancer and lifestyle-associated risk factors. Cancer Communications, 41(11), 1137–1151.PubMedPubMedCentralCrossRef

Siegel, R. L., Miller, K. D., Wagle, N. S., & Jemal, A. (2023). Cancer statistics, 2023. CA: A Cancer Journal for Clinicians, 73(1), 17–48.PubMed

Lutz, A. T., Griza, A., Machado, G. M., Loose, U., Dahmer, A., & Herbert, J. S. (2022). Patient reported outcomes in the daily practice in clinical oncology: A systematic review. Critical Reviews in Oncology Hematology, 173, 103658.PubMedCrossRef

Ahn, S., Jung, H., Kim, S., Shin, S. J., Park, C. G., & Chu, S. H. (2017). Quality of life among Korean gastrointestinal cancer survivors. European Journal of Oncology Nursing, 30, 15–21.PubMedCrossRef

Kaplan, R. M., & Hays, R. D. (2022). Health-related quality of life measurement in public health. Annual Review of Public Health, 43, 355–373.PubMedCrossRef

Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., de Haes, J. C., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365–376.PubMedCrossRef

Montazeri, A. (2009). Quality of life data as prognostic indicators of survival in cancer patients: An overview of the literature from 1982 to 2008. Health and Quality of Life Outcomes, 7, 102.PubMedPubMedCentralCrossRef

10.

Maisey, N. R., Norman, A., Watson, M., Allen, M. J., Hill, M. E., & Cunningham, D. (2002). Baseline quality of life predicts survival in patients with advanced colorectal cancer. European Journal of Cancer, 38(10), 1351–1357.PubMedCrossRef

11.

Efficace, F., Bottomley, A., Coens, C., Van Steen, K., Conroy, T., Schoffski, P., Schmoll, H., Van Cutsem, E., & Kohne, C. H. (2006). Does a patient’s self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer? European Journal of Cancer, 42(1), 42–49.PubMedCrossRef

12.

Comella, P., Casaretti, R., Manzo, R., Sandomenico, C., Licenziato, M., Avallone, A., Franco, L., Southern Italy Cooperative Oncology Group, I. (2010). Baseline physical functioning status of metastatic colorectal cancer patients predicts the overall survival but not the activity of a front-line oxaliplatin-fluoropyrimidine doublet. Acta Oncologica, 49(1), 50–56.PubMedCrossRef

13.

Braun, D. P., Gupta, D., Grutsch, J. F., & Staren, E. D. (2011). Can changes in health related quality of life scores predict survival in stages III and IV colorectal cancer? Health and Quality of Life Outcomes, 9, 62.PubMedPubMedCentralCrossRef

14.

Quinten, C., Martinelli, F., Coens, C., Sprangers, M. A., Ringash, J., Gotay, C., Bjordal, K., Greimel, E., Reeve, B. B., Maringwa, J., Ediebah, D. E., Zikos, E., King, M. T., Osoba, D., Taphoorn, M. J., Flechtner, H., Schmucker-Von Koch, J., Weis, J., Bottomley, A., Patient Reported, O., Behavioral, E., the European Organization for, R., & Treatment of Cancer Clinical, G. (2014). A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites. Cancer, 120(2), 302–311.PubMedCrossRef

15.

Blazeby, J. M., Brookes, S. T., & Alderson, D. (2001). The prognostic value of quality of life scores during treatment for oesophageal cancer. Gut, 49(2), 227–230.PubMedPubMedCentralCrossRef

16.

Fang, F. M., Tsai, W. L., Chiu, H. C., Kuo, W. R., & Hsiung, C. Y. (2004). Quality of life as a survival predictor for esophageal squamous cell carcinoma treated with radiotherapy. International Journal of Radiation Oncology Biology Physics, 58(5), 1394–1404.PubMedCrossRef

17.

Chau, I., Norman, A. R., Cunningham, D., Waters, J. S., Oates, J., & Ross, P. J. (2004). Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer–pooled analysis from three multicenter, randomized, controlled trials using individual patient data. Journal of Clinical Oncology, 22(12), 2395–2403.PubMedCrossRef

18.

Blazeby, J. M., Metcalfe, C., Nicklin, J., Barham, C. P., Donovan, J., & Alderson, D. (2005). Association between quality of life scores and short-term outcome after surgery for cancer of the oesophagus or gastric cardia. British Journal of Surgery, 92(12), 1502–1507.PubMedCrossRef

19.

Park, S. H., Cho, M. S., Kim, Y. S., Hong, J., Nam, E., Park, J., Cho, E. K., Shin, D. B., Lee, J. H., & Lee, W. K. (2008). Self-reported health-related quality of life predicts survival for patients with advanced gastric cancer treated with first-line chemotherapy. Quality of Life Research, 17(2), 207–214.PubMedCrossRef

20.

Djarv, T., Metcalfe, C., Avery, K. N., Lagergren, P., & Blazeby, J. M. (2010). Prognostic value of changes in health-related quality of life scores during curative treatment for esophagogastric cancer. Journal of Clinical Oncology, 28(10), 1666–1670.PubMedCrossRef

21.

Quinten, C., Coens, C., Mauer, M., Comte, S., Sprangers, M. A., Cleeland, C., Osoba, D., Bjordal, K., Bottomley, A., Groups EC. (2009). Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. Lancet Oncology, 10(9), 865–871.PubMedCrossRef

22.

Ediebah, D. E., Quinten, C., Coens, C., Ringash, J., Dancey, J., Zikos, E., Gotay, C., Brundage, M., Tu, D., Flechtner, H. H., Greimel, E., Reeve, B. B., Taphoorn, M., Reijneveld, J., Dirven, L., Bottomley, A., Canadian Cancer Trials, G., the European Organization for, R., & Treatment of, C. (2018). Quality of life as a prognostic indicator of survival: A pooled analysis of individual patient data from Canadian cancer trials group clinical trials. Cancer, 124(16), 3409–3416.PubMedCrossRef

23.

Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Annals of Internal Medicine, 151(4), 264–269.PubMedCrossRef

24.

Wells, G., Shea, B., O'Connell, D., Peterson, J., Welch, V., Losos, M., & Tugwell, P. The Newcastle–Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. Retrieved May 28, 2023, from http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp

25.

Fahmy, O., Fahmy, U. A., Alhakamy, N. A., & Khairul-Asri, M. G. (2021). Single-port versus multiple-port robot-assisted radical prostatectomy: A systematic review and meta-analysis. Journal of Clinical Medicine, 10(24), 5723.PubMedPubMedCentralCrossRef

26.

Zhao, L., Song, Y., Dong, P., Li, Z., Yang, X., & Wang, S. (2014). Brachial pulse pressure and cardiovascular or all-cause mortality in the general population: A meta-analysis of prospective observational studies. Journal of Clinical Hypertension, 16(9), 678–685.PubMedPubMedCentralCrossRef

27.

Begg, C. B., & Mazumdar, M. (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50(4), 1088–1101.PubMedCrossRef

28.

Egger, M., Davey Smith, G., Schneider, M., & Minder, C. (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315(7109), 629–634.PubMedPubMedCentralCrossRef

29.

Hamers, P. A. H., Vink, G. R., Elferink, M. A. G., Stellato, R. K., Dijksterhuis, W. P. M., Punt, C. J. A., Koopman, M., May, A. M., group, Q. s. (2022). Quality of life and survival of metastatic colorectal cancer patients treated with trifluridine-tipiracil (QUALITAS). Clinical Colorectal Cancer, 21(2), 154–166.PubMedCrossRef

30.

Husson, O., de Rooij, B. H., Kieffer, J., Oerlemans, S., Mols, F., Aaronson, N. K., van der Graaf, W. T. A., & van de Poll-Franse, L. V. (2020). The EORTC QLQ-C30 summary score as prognostic factor for survival of patients with cancer in the “Real-World”: Results from the population-based profiles registry. The Oncologist, 25(4), e722–e732.PubMedCrossRef

31.

Fournier, E., Jooste, V., Woronoff, A. S., Quipourt, V., Bouvier, A. M., & Mercier, M. (2016). Health-related quality of life is a prognostic factor for survival in older patients after colorectal cancer diagnosis: A population-based study. Digestive and Liver Disease, 48(1), 87–93.PubMedCrossRef

32.

Ratjen, I., Schafmayer, C., Enderle, J., di Giuseppe, R., Waniek, S., Koch, M., Burmeister, G., Nothlings, U., Hampe, J., Schlesinger, S., & Lieb, W. (2018). Health-related quality of life in long-term survivors of colorectal cancer and its association with all-cause mortality: A German cohort study. BMC Cancer, 18(1), 1156.PubMedPubMedCentralCrossRef

33.

Frank, F., Hecht, M., Loy, F., Rutzner, S., Fietkau, R., & Distel, L. (2020). Differences in and prognostic value of quality of life data in rectal cancer patients with and without distant metastases. Healthcare (Basel), 9(1), 1.PubMedCrossRef

34.

Fitz, T., Sorgel, C., Rutzner, S., Hecht, M., Fietkau, R., & Distel, L. V. (2022). Baseline quality of life of physical function is highly relevant for overall survival in advanced rectal cancer. Healthcare (Basel), 10(1), 141.PubMedCrossRef

35.

Djarv, T., & Lagergren, P. (2011). Six-month postoperative quality of life predicts long-term survival after oesophageal cancer surgery. European Journal of Cancer, 47(4), 530–535.PubMedCrossRef

36.

Chang, Y. L., Tsai, Y. F., Chao, Y. K., & Wu, M. Y. (2016). Quality-of-life measures as predictors of post-esophagectomy survival of patients with esophageal cancer. Quality of Life Research, 25(2), 465–475.PubMedCrossRef

37.

van Kleef, J. J., Dijksterhuis, W. P. M., van den Boorn, H. G., Prins, M., Verhoeven, R. H. A., Gisbertz, S. S., Slingerland, M., Mohammad, N. H., Creemers, G. J., Neelis, K. J., Heisterkamp, J., Rosman, C., Ruurda, J. P., Kouwenhoven, E. A., van de Poll-Franse, L. V., van Oijen, M. G. H., Sprangers, M. A. G., van Laarhoven, H. W. M., & Dutch Upper, G. I. C. G. (2021). Prognostic value of patient-reported quality of life for survival in oesophagogastric cancer: Analysis from the population-based POCOP study. Gastric Cancer, 24(6), 1203–1212.PubMedPubMedCentralCrossRef

38.

van Amelsfoort, R. M., Walraven, I., Kieffer, J., Jansen, E. P. M., Cats, A., van Grieken, N. C. T., Meershoek-Klein Kranenbarg, E., Putter, H., van Sandick, J. W., Sikorska, K., van de Velde, C. J. H., Aaronson, N. K., Verheij, M., & Investigators, C. (2022). Quality of life is associated with survival in patients with gastric cancer: Results from the randomized CRITICS Trial. Journal of the National Comprehensive Cancer Network, 20(3), 261–267.PubMedCrossRef

39.

Mol, L., Ottevanger, P. B., Koopman, M., & Punt, C. J. (2016). The prognostic value of WHO performance status in relation to quality of life in advanced colorectal cancer patients. European Journal of Cancer, 66, 138–143.PubMedCrossRef

40.

Efficace, F., Collins, G. S., Cottone, F., Giesinger, J. M., Sommer, K., Anota, A., Schlussel, M. M., Fazi, P., & Vignetti, M. (2021). Patient-reported outcomes as independent prognostic factors for survival in oncology: Systematic review and meta-analysis. Value Health, 24(2), 250–267.PubMedCrossRef

41.

Nafteux, P., Durnez, J., Moons, J., Coosemans, W., Decker, G., Lerut, T., Van Veer, H., & De Leyn, P. (2013). Assessing the relationships between health-related quality of life and postoperative length of hospital stay after oesophagectomy for cancer of the oesophagus and the gastro-oesophageal junction. European Journal of Cardio-Thoracic Surgery, 44(3), 525–533. Discussion 533.PubMedCrossRef

42.

Giesinger, J. M., Kieffer, J. M., Fayers, P. M., Groenvold, M., Petersen, M. A., Scott, N. W., Sprangers, M. A., Velikova, G., Aaronson, N. K., Group, E. Q. o. L. (2016). Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust. Journal of Clinical Epidemiology, 69, 79–88.PubMedCrossRef

43.

Cocks, K., Wells, J. R., Johnson, C., Schmidt, H., Koller, M., Oerlemans, S., Velikova, G., Pinto, M., Tomaszewski, K. A., Aaronson, N. K., Exall, E., Finbow, C., Fitzsimmons, D., Grant, L., Groenvold, M., Tolley, C., Wheelwright, S., Bottomley, A., European Organisation for, R., & Treatment of Cancer Quality of Life, G. (2023). Content validity of the EORTC quality of life questionnaire QLQ-C30 for use in cancer. European Journal of Cancer, 178, 128–138.PubMedCrossRef

44.

Kumar, K., Mittal, A., Kamboj, D., Goel, G. S., Mittal, A., & Garg, S. K. (2023). Factors affecting quality of life of cancer patients in North India. Asian Pacific Journal of Cancer Prevention, 24(2), 641–648.PubMedPubMedCentralCrossRef

45.

Park, S., Eo, W., & Lee, S. (2018). The relationship between health-related quality of life and survival in metastatic colorectal cancer patients treated with Korean medicine. Integrative Cancer Therapies, 17(1), 65–72.PubMedCrossRef

46.

Wong, C. K., Law, W. L., Wan, Y. F., Poon, J. T., & Lam, C. L. (2014). Health-related quality of life and risk of colorectal cancer recurrence and All-cause death among advanced stages of colorectal cancer 1-year after diagnosis. BMC Cancer, 14, 337.PubMedPubMedCentralCrossRef

Titel: Baseline functioning scales of EORTC QLQ-C30 predict overall survival in patients with gastrointestinal cancer: a meta-analysis
Auteurs: Ye Zang
Yue Qiu
Yimeng Sun
Yu Fan
Publicatiedatum: 16-01-2024
Uitgeverij: Springer International Publishing
Gepubliceerd in: Quality of Life Research / Uitgave 6/2024
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-023-03591-y

Andere artikelen Uitgave 6/2024

Patient adherence and response time in electronic patient-reported outcomes: insights from three longitudinal clinical trials

Cancer population norms using a new value set for the SF-6Dv2 based on the preferences of patients with breast or colorectal cancer in Quebec

Measuring health-related quality of life in children with suspected genetic conditions: validation of the PedsQL proxy-report versions

Association between sleep quality and quality of life in Singapore

Exploratory factor analysis and Rasch analysis to assess the structural validity of the Adult Social Care Outcomes Toolkit Proxy version (ASCOT-Proxy) completed by care home staff

Open Access

Quality of life, cognitive and behavioural impairment in people with motor neuron disease: a systematic review

Open Access
Review